Chemical Component Summary

Name(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL
Identifiersn/a
FormulaC17 H19 N O3
Molecular Weight285.34
TypeNON-POLYMER
Isomeric SMILESC[N@]1CC[C@]23c4c5ccc(c4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)O
InChIInChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1
InChIKeyBQJCRHHNABKAKU-KBQPJGBKSA-N

Chemical Details

Formal Charge0
Atom Count40
Chiral Atom Count5
Bond Count44
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB00295 
NameMorphine
Groups
  • approved
  • investigational
DescriptionMorphine, the main alkaloid of opium, was first obtained from poppy seeds in 1805.[A176035] It is a potent analgesic, though its use is limited due to tolerance, withdrawal, and the risk of abuse.[A176050] Morphine is still routinely used today, though there are a number of semi-synthetic opioids of varying strength such as [codeine], [fentanyl], [methadone], [hydrocodone], [hydromorphone], [meperidine], and [oxycodone]. Morphine was granted FDA approval in 1941.[L12114]
Synonyms
  • Morphine acetate
  • Morphia
  • (−)-morphine
  • Morphine phosphate
  • Morphine hydrochloride trihydrate
Brand Names
  • M.O.S. Sulphate 5mg Tab
  • Morphine Sulfate Oral Solution
  • M.O.S. Sulphate 25mg Tab
  • MorphaBond
  • Statex Suppositories 5mg
IndicationMorphine is used for the management of chronic, moderate to severe pain.[A176050] Opiods, including morphine, are effective for the short term management of pain. Patients taking opioids long term may need to be monitored for the development of physical dependence, addiction disorder, and drug abuse.[L5728]
Categories
  • Alkaloids
  • Analgesics
  • Anesthetics
  • Central Nervous System Agents
  • Central Nervous System Depressants
ATC-Code
  • A07DA52
  • N02AA51
  • N02AA01
  • N02AG01
CAS number57-27-2

Drug Targets

NameTarget SequencePharmacological ActionActions
Mu-type opioid receptorMDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRT...unknownagonist
Kappa-type opioid receptorMDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLE...unknownagonist
Delta-type opioid receptorMEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAI...unknownagonist
Lymphocyte antigen 96MLPFLFFSTLFSSIFTEAQKQYWVCNSSDASISYTYCDKMQYPISINVNP...unknownactivator
Cytochrome P450 2C8MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDMORPHM01
PubChem5288826
ChEBICHEBI:17303
ChEMBLCHEMBL70
PharosCHEMBL70